Stay updated with breaking news from Preclinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ILC's Alfacyte product has potential to become a game-changing antiviral treatment in the ongoing global fight against Covid-19 Scottish biotech ICL Therapeutics has set its sights on a Series A round
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in May 26.04.2023 / 12:30 CET/CEST The issuer is solely responsible
/PRNewswire/ -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive...
Needham (PRWEB) April 20, 2023 -- Bio-IT World today announced the 2023 Innovative Practices Awards winners. Six projects were honored; companies involved in
Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic potential in a broad range of TROP2- and... | April 17, 2023